Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification01:13

Seizures: Classification

2.0K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.9K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.9K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

913
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
913
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulation modeling of neighborhood-level differences in life course health outcomes: a proof of concept.

Innovation in aging·2026
Same author

Respiratory Variability and Sudden Unexpected Death in Epilepsy: Could It Identify Patients at Greatest Risk?

Neurology·2026
Same author

Heart Healthy Ohio Initiative: A Statewide Cooperative to Improve Cardiovascular Risk.

Journal of general internal medicine·2026
Same author

Patient outcomes in KCNQ2 developmental and epileptic encephalopathy.

Developmental medicine and child neurology·2026
Same author

Neurodevelopmental features in KCNQ2 developmental and epileptic encephalopathy may have limited associations with K<sub>V</sub>7.2 dysfunction.

Epilepsia open·2025
Same author

Impact of non-seizure outcomes and caregiver priorities for young people with severe neurodevelopmental encephalopathy with or without epilepsy: A community survey.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2025

Related Experiment Video

Updated: Mar 20, 2026

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K

Epilepsy misconceptions and stigma reduction: Current status in Western countries.

Lynn K Herrmann1, Elisabeth Welter2, Anne T Berg3

  • 1Northern Illinois University, College of Health and Human Sciences, DeKalb, IL, United States.

Epilepsy & Behavior : E&B
|May 22, 2016
PubMed
Summary

Epilepsy misconceptions persist globally, often leading to stigma and exclusion. Current interventions show promise but lack scalability and modern communication strategies for broader impact.

Keywords:
EpilepsyHealth communicationMisconceptionsSeizuresStigma

More Related Videos

Performing Behavioral Tasks in Subjects with Intracranial Electrodes
12:10

Performing Behavioral Tasks in Subjects with Intracranial Electrodes

Published on: October 2, 2014

12.0K
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.5K

Related Experiment Videos

Last Updated: Mar 20, 2026

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K
Performing Behavioral Tasks in Subjects with Intracranial Electrodes
12:10

Performing Behavioral Tasks in Subjects with Intracranial Electrodes

Published on: October 2, 2014

12.0K
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.5K

Area of Science:

  • Neurology
  • Public Health
  • Medical Education

Background:

  • Epilepsy misconceptions contribute to social exclusion and stigma.
  • Understanding and addressing these misconceptions is crucial for improving the quality of life for people with epilepsy (PWE).

Purpose of the Study:

  • To systematically review literature on epilepsy misconceptions in developed Western countries.
  • To identify and evaluate research interventions aimed at reducing these misconceptions.

Main Methods:

  • Systematic literature review of English language publications (2004-2015).
  • Inclusion of original research conducted in Europe, Americas, or Australia.
  • Analysis of studies assessing misconceptions among various populations including the general public, students, and healthcare providers.

Main Results:

  • Eighty-one publications were reviewed, with most studies from the Americas and Europe.
  • Common misconceptions included social exclusion, ignorance about treatment, and stigmatizing overgeneralizations.
  • Prevalence of misconceptions was higher in individuals with less education, lower socioeconomic status, and no prior exposure to PWE.
  • Intervention studies (N=12) showed effectiveness but were often resource-intensive and not scalable for broad implementation.

Conclusions:

  • Epilepsy misconceptions remain consistent, with existing tools potentially missing subtle forms.
  • There is a need for more interventional studies targeting epilepsy stigma.
  • Developing practical, scalable, and technology-based approaches is essential for effective health communication and reducing misconceptions.